SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 217 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,160 | -59.4% | 6,000 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $5,316 | -75.8% | 6,000 | -57.1% | 0.00% | -80.0% |
| Q3 2022 | $22,000 | -21.4% | 14,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $28,000 | -15.2% | 14,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $33,000 | +17.9% | 14,000 | +133.3% | 0.01% | +25.0% |
| Q4 2021 | $28,000 | -68.2% | 6,000 | -47.8% | 0.00% | -71.4% |
| Q3 2021 | $88,000 | -9.3% | 11,500 | +15.0% | 0.01% | -12.5% |
| Q2 2021 | $97,000 | +4.3% | 10,000 | -11.0% | 0.02% | -5.9% |
| Q1 2021 | $93,000 | +12.0% | 11,230 | -8.2% | 0.02% | +6.2% |
| Q4 2020 | $83,000 | -38.1% | 12,230 | +1.9% | 0.02% | -44.8% |
| Q3 2020 | $134,000 | +78.7% | 12,000 | 0.0% | 0.03% | +70.6% |
| Q2 2020 | $75,000 | +400.0% | 12,000 | +50.0% | 0.02% | +325.0% |
| Q1 2020 | $15,000 | +200.0% | 8,000 | +433.3% | 0.00% | +300.0% |
| Q4 2019 | $5,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |